Vifor Pharma: Ferric carboxymaltose by Vifor Pharma Management for Restless Legs Syndrome: Likelihood of Approval
Ferric carboxymaltose is under clinical development by Vifor Pharma Management and currently in Phase III for Restless Legs Syndrome.
Read full article »
Vifor Pharma is a Switzerland-based pharmaceutical company that develops nephrology and cardio-renal therapies for the treatment of heart failure and kidney diseases.
Read more